The good, the bad and the ugly
A medical perspective on clean athletes, dopers and abuse of the system
When I worked with the international medical research team investigating a method for detecting athletes doping with growth hormone (GH), I was struck by the co-operation of the medical teams and the athletes supporting this research in various countries. This project was supported by the International Olympic Committee and the drug companies manufacturing growth hormone who did not want to see this product mis-used.
Why would athletes seek to dope with GH? GH alters body composition by increasing lean mass and decreasing fat mass, a potential advantage for power sports. In addition to this anabolic effect, GH is potentially advantageous to physiology and metabolism in endurance sport by increasing use of lipid over glycogen as a substrate. However there are serious side effects of elevated GH levels as seen in patients suffering with acromegaly: including increased risk of diabetes mellitus, hypertension and cancer.
One of the challenges we encountered in developing a dope test for GH was that endogenously secreted growth hormone was virtually identical to the manufactured product. In addition, this peptide hormone is released episodically in a pulsatile manner and has a short plasma half life. So early on it was realised that direct measurement of growth hormone was not a reliable option, rather quantification of indirect plasma markers would be required. In turn that meant investigating the pharmacokinetic properties of these markers in exercising people.
So far so good. However what are the “normal” ranges for growth hormone and these secondary markers in elite athletes? The ranges used in the usual clinical hospital setting may not be accurate as exercise is a major stimulus for growth hormone release. Part of the reason elite athletes are better than amateur athletes is that they may have slightly different physiology and/or genetically determined physiology that responds more rapidly to training than the rest of us. So the first step was establishing what normal ranges are for growth hormone and its associated markers in elite athletes. Cue trips to Manchester velodrome with portable centrifuges, taking blood from Olympic medal winning rowers at the British Olympic Park and numerous evenings performing VO2 max tests on athletes.
Throughout this research I was struck by the desire of the elite athletes to participate in a study that would identify cheats, allowing them, as clean athletes, to compete on a level playing field. This gave those of us in medical research team extra incentive to come up with the most reliable and robust test possible. Nevertheless, we were aware that an arms race was taking place, with the dopers trying equally hard to cheat our test. Ultimately, however scientifically robust a test may be, it will not succeed if there is manipulation of the samples provided. This is what makes the alleged systemic abuse of the process so ugly.
For further discussion on Endocrine and Metabolic aspects of SEM come to the BASEM annual conference 22/3/18: Health, Hormones and Human Performance
Sports Endocrinology – what does it have to do with performance? Dr N. Keay, British Journal of Sports Medicine
From population based norms to personalised medicine: Health, Fitness, Sports Performance Dr N.Keay, British Journal of Sport Medicine 22/2/17
Keay N, Logobardi S, Ehrnborg C, Cittadini A, Rosen T, Healy ML, Dall R, Bassett E, Pentecost C, Powrie J, Boroujerdi M, Jorgensen JOL, Sacca L. Growth hormone (GH) effects on bone and collagen turnover in healthy adults and its potential as a marker of GH abuse in sport: a double blind, placebo controlled study. Journal of Endocrinology and Metabolism. 85 (4) 1505-1512. 2000.
Wallace J, Cuneo R, Keay N, Sonksen P. Responses of markers of bone and collagen turover to exercise, growth hormone (GH) administration and GH withdrawal in trained adult males. Journal of Endocrinology and Metabolism 2000. 85 (1): 124-33
Keay N. The effects of growth hormone misuse/abuse. Use and abuse of hormonal agents: Sport 1999. Vol 7, no 3, 11-12
Wallace J, Cuneo R, Baxter R, Orskov H, Keay N, Sonksen P. Responses of the growth hormone (GH) and insulin-like factor axis to exercise,GH administration and GH withdrawal in trained adult males: a potential test for GH abuse in sport. Journal of Endocrinology and Metabolism 1999. 84 (10): 3591-601
Keay N, Logobardi S, Ehrnborg C, Cittadini A, Rosen T, Healy ML, Dall R, Bassett E, Pentecost C, Powrie J, Boroujerdi M, Jorgensen JOL, Sacca L. Growth hormone (GH) effects on bone and collagen turnover in healthy adults and its potential usefulness as in the detection of GH abuse in sport: a double blind, placebo controlled study. Endocrine Society Conference 1999
Wallace J, Cuneo R, Keay N. Bone markers and growth hormone abuse in athletes. Growth hormone and IGF Research, vol 8: 4: 348
Cuneo R, Wallace J, Keay N. Use of bone markers to detect growth hormone abuse in sport. Proceedings of Annual Scientific Meeting, Endocrine Society of Australia. August 1998, vol 41, p55